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Michael Edward Fusakio 
ROLE OF ATF4 IN DIRECTING GENE EXPRESSION IN THE BASAL STATE 
AND DURING THE UNFOLDED PROTEIN RESPONSE IN LIVER 
Disturbances in membrane composition and protein folding in the 
endoplasmic reticulum (ER) trigger the unfolded protein response (UPR).  Three 
UPR sensory proteins, PERK (PEK/EIF2AK3), IRE1, and ATF6 are each 
activated by ER stress.  PERK phosphorylation of the alpha subunit of eIF2 
represses global protein synthesis, lowering influx of nascent polypeptides into 
the stressed ER, coincident with the preferential translation of ATF4 (CREB2).  
Results from cultured cells demonstrate that ATF4 induces transcriptional 
expression of genes directed by the PERK arm of the UPR, including genes 
involved in amino acid metabolism, resistance to oxidative stress, and the 
proapoptotic transcription factor CHOP (GADD153/DDIT3).   In this study, we 
characterized two ATF4 knockout mouse models and show in liver exposed to 
ER stress that ATF4 is not required for CHOP expression, but rather ATF6 is a 
primary inducer.  RNA-sequence analysis indicated that ATF4 was responsible 
for a small portion of the PERK-dependent genes in the UPR.  This smaller than 
expected subset of gene expression lends itself to the relevance of UPR 
crosstalk, with ATF6, XBP1, and CHOP being capable of upregulating UPR 
genes in the absence of ATF4.  RNA-sequence analysis also revealed a 
requirement for expression of ATF4 for expression of a comparable number of 
genes basally, including those involved in oxidative stress response and 
cholesterol metabolism.  Consistent with this pattern of gene expression, loss of 
vii 
ATF4 in our mouse model resulted in enhanced oxidative damage and increased 
free cholesterol in liver under stress accompanied by lowered cholesterol in sera.  
Taken together, this study highlights both an expansion of the role of ATF4 in 
transcriptional regulation of genes involved in metabolism in the basal state and 
a more specialized role during ER stress.  These findings are important for 
understanding the variances of the UPR signaling between cell culture and in 
vivo and for a greater understanding of all the roles ATF4 plays within the cell. 
 
Ronald C. Wek, PhD., Chair 
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CHAPTER 1.  INTRODUCTION 
1.1 Stress and the Unfolded Protein Response 
 The endoplasmic reticulum (ER) is a central hub for protein and lipid 
metabolism, and disruptions in ER homeostasis can trigger the Unfolded Protein 
Response (UPR).  The UPR features transcriptional and translational control 
mechanisms that collectively serve to enhance protein folding and assembly, 
thereby expanding the capacity of the ER to process proteins slated for the 
secretory pathway [1-3].  Additionally, the ER is instrumental for intermediary and 
complex lipid metabolism [4].  Among lipids, prudent regulation of cholesterol 
synthesis is critical as cholesterol helps to order phospholipids in membranes.  
UPR sensory proteins, such as the Type 1 ER transmembrane protein kinase 
PERK (EIF2AK3/PEK), are activated by disruptions in protein folding or 
membrane compositions.  The ensuing PERK phosphorylation of the α subunit of 
eIF2 (eIF2α-P) represses global protein synthesis, thereby reducing the influx of 
nascent polypeptides into the overloaded ER.  Coincident with global 
translational control, eIF2α-P enhances preferential translation of a subset of 
stress-related mRNAs, including ATF4 (CREB2), a transcriptional activator of 
UPR target genes [5-7].  Because eIF2α-P induces ATF4 translational 
expression in response to a range of environmental and physiological stresses, 
in addition to those afflicting the ER, the ATF4-directed regulatory scheme has 
been referred to as the Integrated Stress Response (ISR) [2, 6]. 
 Activation of PERK during ER stress is accompanied by induction of the 
additional arms of the UPR that feature ER transmembrane proteins ATF6 and 
2 
IRE1 (Figure 1-1) [1, 8].  Activation of the IRE1 and ATF6 pathways elicit multiple 
downstream effects to limit the strain of proteotoxicity on the cell.  IRE1 is a 
protein kinase and riboendonuclease that serves to facilitate the cytosolic splicing 
of XBP1 mRNA, leading to translation of an activated version of the transcription 
factor, XBP1s, that induces UPR genes involved in protein folding, degradation of 
unfolded or misfolded proteins, and membrane expansion and renewal [9-16].  
The endoribonuclease activity of IRE1 also cleaves mRNAs in the proximity of 
the ER, so-called regulated IRE1-dependent decay (RIDD), which changes the 
composition of mRNAs available for translation [17, 18].  In response to ER 
stress, ATF6 induces transcriptional expression of chaperone proteins necessary 
for assisting in the folding of unfolded proteins and leads to increases in the 
expansion of the ER, increasing its capacity [19, 20]. 
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Figure 1-1 The Unfolded Protein Response.  ER stress leads to the activation 
of the unfolded protein response.  PERK activation leads to the phosphorylation 
of eIF2α and the transcriptional and translational upregulation of ATF4.  IRE1 
activation results in the splicing of XBP1 mRNA, resulting in the active 
transcription factor XBP1s.  Finally, ATF6 is translocated to the Golgi where it 
undergoes a cleavage event releasing the active transcription factor.   
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The UPR sensors PERK, ATF6, and IRE1 pathways are often viewed as 
functioning in parallel and, with branch of the UPR having the potential to elicit 
different effects on cell viability [1, 21, 22].  For example, PERK is posited to 
promote cell death by enhancing CHOP expression, whereas IRE1 is suggested 
to support cell survival during ER stress [21, 23, 24].  Mice with whole body 
knockouts for ATF6 showed delayed recovery from ER stress and decreased 
survival [21].  The premise of distinct sensory pathways in the UPR is challenged 
by the emerging findings that there is cross-regulation between the UPR 
branches.  This idea is illustrated by the report that loss of PERK in cultured cells 
or livers of mice, or deletion of ATF4 in cultured mouse embryonic fibroblast 
(MEF) cells, substantially ablated activation of ATF6 and reduced expression of 
XBP1s during ER stress [25].  Crosstalk in the UPR can also regulate PERK, 
with for example XBP1s inducing transcriptional expression of p58IPK, which is 
reported to lower PERK phosphorylation of eIF2α and translational control [11, 
26].  Therefore, it is likely that the UPR represents an interconnected network of 
regulatory proteins that function together to modulate gene expression that helps 
restore protein homeostasis during the progression of the UPR [27].  
 
1.2 PERK phosphorylation of eIF2 directs translational control  
 The global repression of translation caused by the phosphorylation of the 
α subunit of eIF2 reduces the incoming translational load on the ER [8, 28].  This 
repression is a result of eIF2 being a part of the translation preinitiation complex, 
consisting of 40S ribosomes associated with eIF2 bound with GTP and Met-
5 
tRNAiMet.  The preinitiation complex binds at the 5’- “cap” complex of the mRNA 
and then scans the mRNA processively 5’ to 3’ until it reaches the initiation 
codon.  Prior to reaching the initiation codon, GTP is hydrolyzed to GDP with the 
help of the GAP eIF5, allowing for the joining of the 60S ribosome and formation 
of the 80S ribosome [29].  The eIF2-GDP is released from the translational 
machinery, and the GDP on eIF2 must be exchanged for GTP prior to the next 
round of translation initiation.  This eIF2 exchange occurs through the guanine 
nucleotide exchange factor, eIF2B.  eIF2B is inhibited by eIF2α-P, preventing the 
eIF2-GDP to GTP conversion.  eIF2-GDP is unable to complex with Met-
tRNAiMet, preventing the formation of the 43S complex.  Reduced levels of the 
43S ribosomal complex blocks ribosome loading onto mRNAs and subsequent 
scanning, and as a consequence there are sharp reductions in translation that 
conserve energy during stress conditions [2].     
 Coincident with repression of global protein synthesis, PERK 
phosphorylation of eIF2α leads to preferential translational of select mRNAs, the 
most well-known target being ATF4 [7].  The 5’-leader of ATF4 mRNA contains 
two upstream open reading frames (uORFs) with the second of these two 
elements overlapping out-of-frame with the ATF4 coding sequence (Figure 1-2).  
During periods of non-stress, ribosomes translate the first 5’-proximal open 
reading frame, uORF1, and then due to the higher levels of eIF2-GTP are able to 
rapidly reinitiate at the next ORF, uORF2.  Reinitiation of translation at uORF2, 
which overlaps out-of-frame with the ATF4 coding sequence, prevents synthesis 
of ATF4 protein.  In stress conditions, ribosomes translate uORF1 and resume 
6 
scanning along the 5’-leader of the ATF4 mRNA.  However, with eIF2α 
phosphorylation there are low eIF2-GTP levels that significantly delay the 
scanning ribosome from reacquiring eIF2-GTP coupled with Met-tRNAiMet.  As a 
result the ribosome reinitiates at the ATF4 coding sequence culminating in 
increased ATF4 protein.  Levels of ATF4 protein can also be altered by post-
translational modifications, including phosphorylation, which can allow for 
interaction with SCFβTrCP that leads to the ubiquitination and degradation of ATF4 
by proteasomes [30].  Elevated ATF4 expression and expression of its 
heterodimerization partners directly contributes to increased transcription of its 
targeted genes. 
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Figure 1-2 Control of the expression of ATF4 occurs at multiple steps.  
Control of ATF4 expression occurs at multiple steps involving both the synthesis 
and decay of mRNA and protein.  During a stress event, the half-life of ATF4 
mRNA and protein are increased, leading to increased levels of ATF4 mRNA 
[31].  This increase in stability is accompanied by the translational upregulation 
due to the delayed reinitiation.  ATF4 can undergo post-translational 
modifications, including phosphorylation, which can allow interaction with the 
SCFβTrCP leading to the ubiquitination and degradation of ATF4 [30].  ATF4 
transcriptional activity can also be controlled through the presence of its 
heterodimerization partners.  
 
1.3 Activation of the ATF6 and IRE1 arms of the UPR 
In addition to PERK, two other UPR sensors, ATF6 and IRE1, function to 
regulate transcriptional expression.  Upon ER stress, the accumulation of 
8 
misfolded proteins is suggested to inhibit the interaction between ATF6 and BiP.  
The full-length membrane-bound transcription factor ATF6 is then trafficked from 
the ER to the Golgi by COPII vesicles [32, 33].  In the Golgi, ATF6 undergoes 
regulated intramembrane proteolysis (RIP) via site 1 (S1P) and site 2 proteases 
(S2P), releasing the N-terminal ATF6 segment, ATF6(N) [21, 32, 34-37].  
ATF6(N) then traffics to the nucleus where it induces gene expression associated 
with several downstream functions of the UPR including upregulation of the 
protein chaperone, such as BiP, to assist in proper folding, expansion of the ER, 
and upregulation of expression of XBP1 [15, 19, 20, 38].  Mutations in ATF6, 
have been associated with photoreceptor degeneration and achromatopsia [39, 
40], conditions which are associated with reduced visual acuity or blurriness and 
sensitivity to light. 
During ER stress, IRE1 undergoes oligomerization and 
transautophosphorylation, which are also hallmark features of PERK activation 
[41].  These events lead to the activation of IRE1 endoribonuclease activity.  As 
described earlier, IRE1 initiates the cytosolic splicing of XBP1 mRNA, which 
removes a 26 nucleotide segment from the XBP1u mRNA.  This cleavage event 
and the subsequent ligation of XBP1 by the catalytic subunit of the tRNA ligase 
complex result in a translation frame shift, which removes a stop codon allowing 
for translation of active XBP1s [42].   
 
1.4 ER stress and transcriptional control 
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 ATF4 serves to enhance transcriptional expression of genes involved in 
amino acid metabolism and resistance to oxidative stress [6, 43-45].  ATF4 also 
upregulates the transcription of many of the genes involved in amino acid 
synthesis [6, 46].  Most notable is the transcription of the gene ASNS, encoding 
asparagine synthetase, which catalyzes the conversion of aspartate to 
asparagine [43].  Activation of the ASNS gene occurs at a promoter element 
known as an Amino Acid Response Element (AARE) [47].  ATF4 binding at the 
AARE element, as with many of its target genes, requires ATF4 
heterodimerization with other basic zipper proteins, such as C/EBPβ.  Binding of 
ATF4 heterodimers at the AARE elements in target gene promoters can result in 
histone acetylation, which leads to the recruitment of general transcription 
machinery including RNA polymerase II, leading to induced gene transcription 
[48].  During prolonged periods of stress, ATF4 heterodimerization and binding at 
AAREs can be disrupted by increased expression of ATF3.  ATF3 can compete 
with ATF4 for interaction with C/EBPβ, thereby decreasing ATF4 binding at target 
promoters, such as ASNS, which lowers gene expression.  Thus, there is a 
dynamic process of ATF4-directed gene expression during the progression of a 
stress response, with an early full induction of target genes, followed by a 
dampening of expression as a network of transcription factors is expressed and 
differentially engages with the promoters of stress responsive genes.  
ATF4 has a major role in prevention of oxidative stress.  This is illustrated 
by the finding that ATF4 depletion in MEF cells, even in the absence of apparent 
stress sharply increases oxidative stress as measured by a reduction in cell 
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death upon the addition of antioxidant [6].  As a consequence, ATF4-/- MEF cells 
demonstrated lowered survival unless the medium was supplemented with 
reducing agents, such as cysteine or β-mercaptoethanol.  Cysteine is a major 
component of the synthesis of glutathione, a reductant in the cell [49], and ATF4 
was found to be important for expression of CTH (or CSE), a gene responsible 
for converting cysteine from cystathionine, for the purpose of generating 
glutathione [46].   
ATF4 also functions to induce expression of another transcription factor, 
CHOP, and ATF4 and CHOP independently or in combination are thought to 
coordinate key facets of the UPR transcriptional and translational control directed 
by PERK [6, 50-55].  For example, together ATF4 and CHOP induce the 
expression of GADD34, which serves to direct feedback dephosphorylation of 
eIF2α-P [55-59].  ATF4 and CHOP also function in a feedforward loop to induce 
expression of a related transcription factor ATF5, and this transcription network is 
central for determining cell fate in response to ER stress [51].   
 
1.5 Nutrient stress and ATF4 transcriptional control 
 Mammalian cells sense amino acid availability via two mechanisms, the 
first being the mTORC1 pathway which functions to maintain a necessary 
quantity of amino acids to maintain the current protein rate of synthesis and cell 
growth [60, 61].  mTORC1 activation during periods of high amino acid content 
occurs at the surface of late endosomes and lysosome via Rag complexes [62].  
High levels of amino acids cause Ragulator to activate RagA, resulting in the 
11 
formation of active RagA/RagC complex, which recruits mTORC1 to the 
lysosome and allows its interaction with Rheb, which activates mTORC1 [62, 63].  
Deficiency for essential amino acids also triggers the amino acid response 
pathway.  This pathway features activation of GCN2, which phosphorylates 
eIF2α and triggers repression of general translation, which serves to conserve 
consumption of amino acids [2, 61].  Coincident with the regulation of global 
protein synthesis, eIF2α-P selectively enhances expression of certain genes that 
serve to restore the levels of the depleted amino acid.  ATF4, which as noted 
earlier is preferentially translated during periods of eIF2α phosphorylation, is a 
central regulator of genes involved in nutrient uptake and metabolism, including 
ASNS and the amino acid transporter SLC7a11, and genes that participate in 
protein degradation, which collectively serve to increase the pool of available 
amino acids [2].  ATF4 also induces expression of Sestrin2, which regulates Rag 
GAP complex GATOR [64, 65].  The ATF4 connection to mTORC1 is also 
present in hypoxic stress through ATF4 induction of REDD1, which also inhibits 
mTORC1 signaling [66].  This stress response results in similar outcomes to the 
PERK driven stress response, with GADD34 driven dephosphorylation of eIF2α 
leading to a restoration of general synthesis or in cases of prolonged stress, cell 
death.  
 
1.6 Oxidative stress and the Unfolded Protein Response 
 Reactive oxygen species at appropriate concentrations play a beneficial 
role and allow for certain necessary reactions to occur in cells.  These beneficial 
12 
effects include energy production through oxidative phosphorylation, cellular 
growth, and degradation via the peroxisomes [67, 68].  When levels of ROS 
exceed the antioxidant defense of cells, ROS instead results in lipid peroxidation 
and damage to DNA [68].  ROS can be generated by several organelles in the 
cell, with the mitochondria and the ER being two of the major sources of ROS.  
ROS generation in the ER occurs as a result of the ER environment promoting 
protein disulfide bond formation via the protein disulfide isomerase family.  
Glutathione in the ER acts to reduce disulfide bonds, generating oxidized 
glutathione, which is at much higher levels in the ER than other compartments of 
the cell [68].  However, ROS production in the mitochondria results as a by-
product of energy production from the electron transport chain.  
 PERK-/- cells have been shown to accumulate endogenous peroxides 
during ER stress, demonstrating the important role of the UPR in alleviating 
oxidative damage [6].  However, PERK-deficient cells did not show accumulation 
of peroxides in basal conditions or need reducing agent supplementation in the 
medium.  By comparison, ATF4-/- MEF cells failed to thrive in basal conditions 
without supplementation of the media with an antioxidant [6].  Genome-wide 
mRNA analysis via microarray of cells depleted for ATF4 indicated that this 
transcription factor is critical for expression of genes involved in the metabolism 
of sulfur-containing amino acids, which is likely one important reason for the 
antioxidant functions of ATF4 [6].   
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1.7 Cholesterol and Lipid Metabolism and the Unfolded Protein Response  
 The liver plays a major role in the processing of lipids, and the ER serves 
as the major locus for lipid metabolism within the liver [69].  Fatty acids are 
generated from the hydrolysis of triglycerides in lipid droplets, uptake from the 
circulation, or via de novo synthesis.  Lipid levels are controlled primarily through 
the sterol regulatory element-binding protein (SREBP) family of transcription 
factors.  SREBP1c is necessary for the de novo lipid synthesis, whereas 
SREBP2 regulates cholesterol metabolism [70].  Like ATF6, the SREBPs are 
transcription factors activated by regulated intramembrane proteolysis (RIP) and 
are released from the ER membrane through an interaction with the proteins 
SCAP and INSIG [37].  Dissociation of SREBP/SCAP from INSIG due to low 
sterol levels results in SREBP transport to the Golgi.  Once in the Golgi, SREBP 
undergoes a cleavage event by the same proteases that cleave ATF6, S1P and 
S2P [71].  SREBPs are then translocated to the nucleus where they activate 
genes involved in lipid and cholesterol metabolism.  ER stress has been shown 
to increase the proteolytic cleavage of SREBPs by degradation of INSIG [69]. 
However, ER stress elicited by tunicamycin represses transcription of SREBP1 
[70].   
 Cholesterol levels within the liver are maintained via multiple pathways 
involving synthesis, export, and import via particular transporters, esterification, 
and conversion into bile acids.  Approximately 10-20% of cholesterol synthesis 
occurs within the liver and originates with the conversion of three molecules of 
acetate into 3-hydoxy-3-methyglutaryl coenzyme A (HMG-CoA) [72, 73].  HMG-
14 
CoA is then converted to mevalonic acid by HMG-CoA reductase, and after 
several additional biochemical steps forms cholesterol.  HMG-CoA reductase is 
the rate-limiting step and can be inhibited by high levels of cholesterol in a 
negative feedback loop.  Cholesterol cannot be broken down into carbon and 
water and thus must be removed through conversion or excretion.  Of the 
cholesterol that enters the intestinal system, 50% will be reabsorbed, with the 
remainder being excreted via the stool.  HMG-CoA reductase levels are 
upregulated by SREBP2, whose activation is controlled in a manner similar to 
SREBP1 [73].  Whereas SREBP2 levels do not appear to be reduced in 
response to stress, expression of HMG-CoA reductase is lowered in the liver 
[25].  Dysfunction in the cholesterol biosynthetic pathway is believed to play a 
role in the development and/or progression of non-alcoholic fatty liver disease 
and non-alcoholic steatohepatitis (NASH).  Patients with non-alcoholic fatty liver 
disease demonstrate increased expression of active SREBP2 and HMG-CoA, 
which correlate to increased free cholesterol levels [73].  Tight regulation of 
cholesterol synthesis is required to ensure a balance between maintaining 
membrane integrity and proper cellular metabolism and preventing accumulation 
of potentially damaging cholesterol. 
 Previous studies have suggested that PERK plays a role in lipid 
homeostasis.  Liver-specific PERK knockout (LsPERK-KO) mice showed 
increased levels of Oil Red O after 12-hour tunicamycin treatment, signifying an 
increase in fat deposits [25].  Livers from LsPERK-KO mice also displayed 
increased levels of triglycerides after 12 hours of the tunicamycin treatment.  
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SREBP1 expression was reduced in WT and LsPERK-KO mice in response to 
stress, despite the accumulation of lipids, suggesting that accumulation of lipids 
results from a failure to excrete or metabolize lipids rather than an increase in 
lipid synthesis. 
 
1.8 ATF4 regulates gene expression during the basal state and has tissue-
specific functions  
Expression of ATF4 is typically viewed in the context of stress responses, 
where ATF4 levels can be increased in multiple tissue types including liver, 
pancreas, brain, and brown and white adipose tissues [74].  Yet, there is growing 
evidence that ATF4 has a role that pertains to the development of different tissue 
types (Figure 1-3), as well as a role in mitochondrial functions. 
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Figure 1-3. ATF4 and its Role in Physiology.  Loss of ATF4 has been 
associated with several physiological alterations.  ATF4 knockout mice 
demonstrate a failure of certain cells to differentiate in their eyes, bones, and 
reproductive organs [75-77].  The ATF4-/- mice also show anemia in the fetal 
liver, and lack of angiogenesis in the bone [78].  ATF4-/- mice also present with 
resistance to muscle weakening due to fasting or old age [79, 80].   
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ATF4 knockout mice are born with severe microphthalmia and absent lens 
[77].  Eye lens development results from two differentiation processes.  The 
primary lens differentiation in ATF4-/- mice occurs normally, with primary lens 
fiber cells showing no significant difference between wild-type (WT) and ATF4-/- 
mice at E14.5 [77].  Differentiation of secondary lens fiber cells results from the 
proliferation of lens epithelial cells and subsequent conversion of these cells into 
secondary fiber cells.  Loss of ATF4 did not lead to alteration in the proliferation 
of epithelial cells but did impede differentiation of secondary lens fiber cells, 
resulting in the failure to generate a lens [77].   
 ATF4 is also suggested to impede differentiation of other tissues and may 
help explain the infertility issues commonly associated with the ATF4-/- mice [78].   
The morphology of sperm from ATF4-/- and WT mice were found to be similar 
and capable of causing in vitro fertilization of WT embryos [75].  However, 
examination of the vas deferens from ATF4-deficient mice led to the discovery 
that there were alterations in the thickness of the tissues layers, and the lumen 
layer was reduced in diameter.  The morphological differences in ATF4-/- mice 
were suggested to result from failure of elastin in the lamina propria to 
polymerize into elastic fibers during sexual maturation [75].  These 
developmental changes were seen at 10 weeks of age, while the mice appeared 
morphologically similar to WT at 5 weeks of age, prior to sexual maturation. 
One of the most notable phenotypes observed in ATF4-/- mice occurs in 
bone.  ATF4-deficient mice demonstrated reduced area of mineralized tissue 
within the frontal and parietal bones, along with the clavicle and long bones [76].  
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This delay in mineralization was also seen within the skull of the ATF4-deleted 
mice.  Similar to what was seen in eye development, early skeletogenesis was 
unaffected by the loss of ATF4, with day E13 WT and ATF4-/- mice displaying no 
differences [76].  However, at E16, there was a noticeable difference in 
osteoblast differentiation.  The osteoblast phenotype was attributed to an 
important role of ATF4 in expressing target genes involved in osteogenesis, such 
as osteocalcin [76].  Expression of osteocalcin is dependent upon ATF4 
interaction with the OSE1 element in the promoter of the osteocalcin gene [81].  
ATF4 binds first to the OSE1 element and then interacts with the general 
transcription factor TFIIAγ, which also engages with Runx2 and drives 
osteocalcin expression.  These gene expression changes culminate in a 
significant reduction in bone mass in ATF4-/- mice [76].  Intriguingly, not all of the 
effects of ATF4 on bone development are thought to be anabolic.  There is also 
evidence that ATF4 has a catabolic role in bone formation by controlling the 
differentiation of osteoclast.  Histological sections of ATF4-/- mice showed 
reduced levels of the osteoclast enzyme tartrate-resistant acid phosphatase and 
lowered levels of NFATc1, the master regulator of osteoclast differentiation [82].  
ATF4 was shown to bind to the promoter region of the NFATc1 gene in 
osteoclast-like cells upon RANKL induction, suggesting a direct role of ATF4 in 
driving the differentiation of osteoclasts, and its loss leads to a severe deficiency 
in osteoclast differentiation.   
Catabolic functions of ATF4 are also seen in the muscle, where ATF4 has 
been associated with muscle weakness and atrophy [79, 80, 83].  During fasting 
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conditions it was shown that depletion of ATF4 expression in muscle prevented 
the decrease seen in fiber diameter following fasting [79].  In the absence of 
fasting, the fiber diameter was also reduced upon overexpression of ATF4.  This 
reduction in fiber density may result from lowered expression of five ATF4-target 
genes, CDKN1A, CSRP3, PEG3, GADD45A, and ANKRD1 [79].  A role for ATF4 
in the induction of muscle atrophy was also seen in response to limb 
immobilization [83].  ATF4 is also suggested to play a role in the loss of muscle 
due to aging.  Ursolic acid and tomatidine were determined to reduce age-related 
decreases in muscle strength and mass by a mechanism suggested to involve 
depletion of ATF4 expression and activity [80].  The precise drug targets for 
lowered expression of ATF4 are currently unclear, but repression of ATF4 
transcriptional expression was reported during UV stress through the C/EBPβ Lip 
isoform binding to the promoter region of ATF4 and preventing its transcription, 
and ATF4 mRNA is subject to decay by nonsense-mediated RNA decay [5, 84, 
85]. 
 
1.9 The Unfolded Protein Response and Disease  
 The UPR is suggested to trigger either cell survival or cell death 
depending on the nature and duration of the underlying stress [24, 54]. 
Furthermore in certain diseases, the UPR is unable to properly function due to 
genetic mutations that can lead to failure of segments of the UPR network to 
properly remedy stress.  Wolcott-Rallison syndrome is a rare disease in patients 
with truncations or missense mutations in PERK [86].  This syndrome presents 
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with neonatal or early onset diabetes, as well as hepatic and renal complications, 
lowered bone mineral density, and developmental delay including mental 
retardation [86].  Patients with loss of PERK function die early in childhood.   
 Mutations have also been found in other UPR members.  As noted earlier, 
patients with ATF6 deficiencies have eye disorders, with achromatopsia or 
retinitis pigmentosa [39, 40].  Achromatopsia involves defects in color perception 
and acuity in high light, along with blurred vision in normal light exposure [40].  
Retinitis pigmentosa is a type of photoreceptor neurodegeneration of the rod 
photoreceptor cells in the eye, which will eventually result in loss of cone cells of 
the eye [39].  This results in a progressive loss of vision by the individual.  While 
a range of phenotypes is associated with ATF4-deficient mice, there are currently 
no known human diseases originating from mutations in ATF4. 
 The UPR is also thought to play a role in progressive diseases, such as 
cancer and fatty liver disease.  ATF4 is suggested to be an integral part of the 
epithelial to mesenchymal transition, which is required for metastasis of certain 
tumors [87].  Once detached, cells must resist cell death resulting from the loss of 
attachment, also called anoikis.  Recent studies have shown that ATF4 promotes 
resistance to anoikis by upregulating autophagic and antioxidant responses [88]. 
The UPR has also been linked to inflammation, which occurs in the pathogenesis 
of NASH.  Prolonged activation of the UPR resulting in CHOP expression, an 
ATF4-target gene, triggers activation of the pro-inflammatory NF-κB [89]. NF-κB 
then induces the expression and secretion of cytokines, leading to cell death and 
inflammation in the surrounding tissue.  Recent studies have also noted that free 
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cholesterol accumulation in liver tissues correlates with the severity of the NASH 
[73].  Collectively, increased cholesterol levels, inflammation, and cell death are 
suggested to contribute to the progression towards fibrosis often observed in 
NASH patients.   
 
1.10 Role of ATF4 in the liver during the Unfolded Protein Response 
The results in Chapter 3 of this thesis focus on the central role of ATF4 in 
controlling transcriptional expression directed by PERK.  In order to determine 
the functional roles of ATF4 in the UPR, we measured the UPR transcriptome in 
mice deleted for ATF4 in the liver and compared those changes with gene 
expression patterns altered by depletion of ATF4 in cultured cells.  While 
expression of ATF4 is induced in response to stress and the transcription factor 
plays a role in stress adaptation, a similar number of genes show ATF4-
dependence for mRNA expression in basal conditions, with no apparent stress.  
ATF4 plays a role in these conditions in anti-oxidation and in cholesterol 
metabolism.  Importantly, we also showed that ATF4 was required for only a 
subset of PERK-dependent genes in vivo.  Distinct from loss of PERK in liver, we 
found that deletion of ATF4 in liver was not required for induction of either UPR 
transcription factors CHOP or ATF6 during ER stress.  Furthermore, deletion of 
ATF4 showed a ten-fold increase in hepatocyte cell death in response to ER 
stress.  Although significant, the level of cell death resulting from deletion of 
ATF4 in liver was only a fraction of the cell death determined for PERK 
deficiency.  
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CHAPTER 2.  EXPERIMENTAL METHODS  
 This section will describe the techniques used in experiments and analysis 
described in this thesis.  These experimental methods will also note points of 
interest and experimental considerations when studying the UPR.   
 
2.1 Cell Culture   
 WT and ATF4-/- MEF cells [6], mouse hepatoma Hepa1-6 cells and 
HEK293T were cultured in DMEM (4.5 g/l glucose) supplemented with 1x 
nonessential amino acids (HyClone SH3023.01), 1x MEM essential amino acids 
(HyClone SH30598.01), and 50 μM β-mercaptoethanol, as described previously 
[6].  Cultured cells were treated with solvent alone referred to as no no treament 
(NT), 2 μM tunicamycin (Tm), 1 μM MG132, or 50 nM halofuginone (HF), for the 
indicated times.  Cultured cells that were treated with halofuginone were first 
washed with PBS to remove DMEM media to ensure the removal of amino acids, 
prior to addition of media containing dialyzed FBS and subsequent addition of 
halofuginone.  The timing and concentration of the drug are important for each 
UPR experiment.  Induction of UPR mRNA expression can occur as early as 3 
hours making it a good initial time point.  At 6 hours most members of the UPR 
can be detected via immunoblot analyses.  Apoptotic markers are detectable 
starting between 12 to 24 hours of pharmacological induction of ER stress.   
shRNA-directed knockdowns of ATF4, ATF5, ATF6, and CHOP, were 
performed using a lentivirus delivery system featuring Addgene third-generation 
plasmids and mission shRNA clones (Sigma-Aldrich, St. Louis, MO) for 
generation of the viral particles.  The shRNAs used in this study are as follows: 
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ATF4: TRCN0000071726, TRCN0000071727, ATF5: TRCN0000075556, 
TRCN0000075553, ATF6: TRCN0000321326, TRCN0000321328, CHOP: 
TRCN0000103709, TRCN0000305677, and control Ctrl: TRC2-puro SHC201V.  
Plasmids WB984, WB985, and WB986 encoding the viral packaging and 
envelope components, along with the particular shRNA plasmid were co-
transfected into HEK293T cells using the transfection reagent Fugene 6.  On day 
2 the media was replaced with a media containing 25mM HEPES buffer.  Media 
was collected on days 3 and 4.  This media was then added to the Hepa1-6 cells 
for 8 hours prior to at least 12 hours of recovery in normal DMEM media.  The 
selection was performed using puromycin (10 μg/ml) and occurred until a non-
transfected plate was devoid of cells.  The shRNA Hepa1-6 cell lines were then 
expanded and examined for knockdown level.   
 
2.2 Measurement of eIF2α-P and the UPR by immunoblot analyses 
 Cellular lysates were prepared from cultured MEF cells and Hepa1-6 cells 
using RIPA-buffered solution containing 50 mM Tris-HCL (pH 7.5), 150 mM 
sodium chloride, 1% Nonidet P-40, 0.1% SDS, 100 mM sodium fluoride, 17.5 mM 
β-glycerophosphate, 0.5% sodium deoxycholate, and 10% glycerol, that was 
supplemented with EDTA-free protease inhibitor cocktail (Roche, Basel, 
Switzerland).  Protein concentrations were determined by the Lowry assay with 
the Bio-Rad DC protein quantification kit according to manufacturer’s instructions 
(Bio-Rad, Hercules, CA cat no: 500-0113 and 500-0114).  Equal concentrations 
of protein from each sample were prepared in 2x SDS sample buffer and heated 
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at 95°C for 5 minutes.  Precision Plus Protein All Blue Prestained Protein 
Standard (Bio-Rad, Hercules, CA cat no: 1610373) was added to the SDS 
polyacrylamide gel to determine molecular weights.  SDS gels were made at 
either 12% acrylamide or a gradient gel of 4-20% (Novus Biolgocials, Littleton, 
CO cat no: NBP1-78903).  Gel electrophoresis was then followed by transfer of 
proteins to nitrocellulose membranes.  Membrane blots were incubated for 1 hour 
in 5% (w/v) nonfat milk powder in PBS with 0.2% Tween-20.  Primary antibody in 
5% nonfat milk powder was added to the blot overnight, and blots were then 
washed in PBS with a solution of 0.2% Tween-20 for 1 hour.  Secondary 
antibody either to rabbit or mouse depending on the primary antibody was then 
added at a dilution of 1:3000, followed by an additional wash step for 1 hour.  
Proteins were detected either via enhanced chemiluminescence or Odyssey 
infrared systems.  Enhanced chemiluminescence expression was performed 
using a combination of two developing solutions made in the lab.  Solution 1 
contained 100 mM Tris-HCl (pH 8.5), 2.5 mM 3-aminophthalydrazide (Luminol; 
Sigma-Aldrich #A-8511) and 0.4 mM P-coumaric acid (Sigma-Aldrich #C-9008) 
was kept from exposure to light.  Solution 2 contained 100 mM Tris-HCl (pH 8.5) 
and H2O2 (stock 30%) at a final concentration of 0.02%.  The combination of 
solution 1 and 2 was then added to the membrane and exposed to film. 
Primary and secondary antibodies used in immunoblot analyses include 
those from Abcam (Cambridge, United Kingdom) recognizing eIF2α-P (ab32157), 
and from Cell Signaling Technology (Danvers, MA) antibodies for Actin (#8457). 
Antibodies for GADD34 (sc-8327) and CHOP (sc-7351) were purchased from 
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Santa Cruz Biotechnology (Santa Cruz, CA). The eIF2α total antibody was a kind 
gift from the laboratory of Dr. Scot Kimball (Pennsylvania State University 
Medical School).  ATF6 antibody was prepared in rabbits using the mouse ATF6 
N-terminal amino acid residues 6-307 as the antigen and was used at a 
concentration of 1:250 in 5% milk powder in PBS with 0.2% Tween20, as 
previously described [25].  ATF4 and ATF5 antibodies were prepared against the 
corresponding recombinant human proteins, which were affinity purified.  
Secondary antibodies were purchased from BioRad (Hercules, CA).  The 
Odyssey infrared imaging system (LI-COR, Lincoln, NE) was used to visualize 
actin, total eIF2α, and CHOP antibodies.  Protein levels were measured by 
densitometry using the program ImageJ [90]. 
Flash frozen liver tissue samples were prepared for immunoblot analysis 
through homogenization via sonication in 1 ml of RIPA.  Lysates were then 
clarified by centrifugation at 13,000 x g for 30 minutes.  Supernatants were 
analyzed via the Lowry assay.  Equal concentrations of proteins were separated 
by electrophoresis in an SDS-polyacrylamide gel, followed by transfer to 
nitrocellulose membranes, blocking with 5% nonfat powder milk, and overnight 
incubation with primary antibody as described above.  The methods of detection 
for liver samples were the same as those for cell culture.  Liver samples required 
a higher primary antibody concentration for protein detection compared to 
proteins lysates prepared from cell culture. 
 
26 
2.3 Interpreting the observed induction of eIF2α-P and the UPR activation 
during ER stress. 
 eIF2α phosphorylation can occur via one of four protein kinases, and the 
downstream effectors activated vary depending on the type of stress.  It is 
important to use control measurements of UPR or nutrient starvation to confirm 
that the expected stress pathway is activated by the experimental stress 
condition.  For example, induction of ATF6(N) or XBP1s is thought to be 
restricted to ER stress.  ATF6 cleavage and detection of ATF6(N) is thought to 
occur upon disruption of the ER.  Induction of ATF6 mRNA, however, can occur 
in response to nutritional stresses, so care must be taken to ensure detection of 
ATF6(N) via immunoblot analysis (Figure 3-1B, 3-3A).  Induction of XBP1s, 
which is a consequence of activation of IRE1 in response to ER stress, is absent 
or even repressed in response to nutritional stress, making it another excellent 
marker of ER stress (Figure 3-1A, 3-3A).  
 
2.4 Animals  
 Animal protocols were approved by the Institutional Animal Care and 
Use Committees at Rutgers, The State University of New Jersey and Indiana 
University School of Medicine, Indianapolis, IN.  Whole Body ATF4 knockout 
mice (WbATF4-KO) were described [78] and obtained from the Jackson 
Laboratory (Bar Harbor, Maine).  C57BL/6J mice homozygous for the LoxP 
allele of ATF4 (ATF4fl/fl) [91] were bred with C57BL/6J mice heterozygous for 
the Cre recombinase gene under an albumin gene promoter (AlbCre) to create 
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a liver-specific knockout of ATF4, LsATF4-KO (AlbCre-* ATF4fl/fl).  Cre-
negative mice from these litters expressed WT levels of ATF4 and were used 
as controls.  Genotyping showed efficient ATF4 gene deletion, and proteins 
level reductions were seen in response to Tm treatment (Figures 5, A and E).  
Female adult mice (n = 5-8 per treatment group), aged 3 to 6 months were 
individually housed in plastic cages with soft bedding, maintained on 12 hour 
light/dark cycles, and freely provided tap water and commercial pelleted diet 
(5001 Laboratory Rodent Diet, LabDiet).  Mice received intraperitoneal (IP) 
injections of tunicamycin at a dose of 1 mg/kg body weight, whereas control 
mice were given a vehicle consisting of a solution of 0.3% dimethyl sulfoxide 
(DMSO) in phosphate-buffered saline.  Mice were killed by decapitation using 
a rodent guillotine at 6, 24, and 36 hours after treatment, as indicated.  Livers 
were rinsed with ice-cold PBS and then snap frozen in liquid nitrogen or fixed 
in 4% paraformaldehyde.  Mice homozygous for the LoxP allele of PERK 
(PERK/fl) were previously described [25] and were bred with transgenic mice 
heterozygous for the Cre recombinase gene under an albumin gene promoter 
(AlbCre) to create a liver-specific knockout of PERK, LsPERK-KO (AlbCre-* 
PERK/fl).  Cre-negative mice from these litters expressed WT levels of PERK 
and were used as controls. 
 
2.5 Reverse Transcription and Real-Time PCR  
 Total RNA was extracted from cultured Hepa1-6 and MEF cells and from 
liver tissues by using TRIzol reagent (Life Technologies, Grand Island, NY) 
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following the manufacturer’s instructions, which yielded preparations with 
A260/A280 ratios between 1.8 and 2.0 as observed by spectrophotometry.  
Reverse transcription was performed with 1 μg of each RNA sample using the 
High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, 
CA) according to the manufacturer’s instructions.  Levels of the indicated mRNAs 
were determined by qPCR.  Primers used for SYBR Green are listed in Table 2-
1.  Amplification and detection were measured on the Realplex2 Master Cycler 
(Eppendorf, Hauppauge, NY).  All experiments were performed with at least 3 
biological replicates and with technical replicates.  Results were generated using 
comparative Ct method and are expressed as fold change relative to the 
untreated control. 
 
Table 2-1.  Sequence of Primers for SYBR green based qRT-PCR. 
Name Forward Reverse 
Abca1 AACAGTTTGTGGCCCTTTTG AGTTCCAGGCTGGGGTACTT 
Abcg5 CGTCCAGAACAACACGCTAA GCAGCATCTGCCACTTATGA 
Abcg8 AAGACGGGCTGTACACTGCT AGGAGGACATGTGGAAGGTG 
Actin TGTTACCAACTGGGACGACA GGGGTGTTGAAGGTCTCAAA 
ASNS TTGACCCGCTGTTTGGAATG CGCCTTGTGGTTGTAGATTTCAC 
ATF4 GCCGGTTTAAGTTGTGTGCT CTGGATTCGAGGAATGTGCT 
ATF5 GGCTGGCTCGTAGACTATGG CCAGAGGAAGGAGAGCTGTG 
ATF6 GATGCAGCACATGAGGCTTA CAGGAACGTGCTGAGTTGAA 
BiP TGCAGCAGGACATCAAGTTC TACGCCTCAGCAGTCTCCTT 
CHOP CGGAACCTGAGGAGAGAGTG CGTTTCCTGGGGATGAGATA 
CTH TGCTAAGGCCTTCCTCAAAA AAGCTCGATCCAGGTCTTCA 
CYP7A1 ACACCATTCCTGCAACCTTC GCTGTCCGGATATTCAAGGA 
CYP27A1 TCTGGCTACCTGCACTTCCT CTGGATCTCTGGGCTCTTTG 
FGF21 AGATGGGCTCTCTATGGATCG GGGCTTCAGACTGGTACACAT 
GADD34 AGGACCCCGAGATTCCTCTA CCTGGAATCAGGGGTAAGGT 
HNF4a GGTCAAGCTACGAGGACAGC ATCCAGAAGGAGTTCGCAGA 
nCEH1 TTCTGGAGACAGTGCTGGTG GGATCGGAGTGTTCATGCTT 
SOAT2 GTGCCTGGGATCTTTTGTGT GGATGAAGCAGGCATAGAGC 
SOD2 CCGAGGAGAAGTACCACGAG GCTTGATAGCCTCCAGCAAC 
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XBP1t AAGAACACGCTTGGGAATGG ACTCCCCTTGGCCTCCAC 
XPB1s GAGTCCGCAGCAGGTG GTGTCAGAGTCCATGGGA 
 
2.6 Histology 
  Tissues were fixed in 4% paraformaldehyde, frozen, and then sectioned at 
10 μm, using a cryostat.  TUNEL assays were performed according to the 
manufacturer’s instructions (Trevigen TACS 2 TdT-Blue Label In Situ Apoptosis 
Detection Kit; R&D System, Minneapolis, MN).  TUNEL- positive cells were 
measured from equally sized sections of livers derived from a similar location 
within the tissues.  Digital images of the selected areas were prepared at 200x 
and imported into Scion Image for Windows (Scion Corporation, Frederick, MD), 
and TUNEL-positive cells were manually marked and counted.   
 
2.7 Cholesterol Measurements  
Cholesterol content was measured in lysates prepared from liver tissues 
by using the Amplex Red Cholesterol assay kit (Molecular Probes, Eugene, OR).  
Cholesterol standards, liver lysate samples, and resorufin positive control were 
placed into a 96 well plate in a volume of 50 μl (100 μl for the resorufin) per well, 
prior to the addition of the working solution of 300 μM Amplex Red reagent.  
Plates were then incubated for 30 minutes at 37°C, protected from light sources.  
Resorufin, the product of the amplex red reagent, was then measured in a 
Synergy H1 (BioTek, Winooski, VT) fluorescence microplate reader using 
excitation at 530 nm and emission detection of 590 nm.  Fluorescence intensity 
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was then used to calculate the amount of cholesterol (μg) based on the standard 
curve, which was normalized for protein concentrations determined for lysates. 
 
2.8 RNA-Seq Analysis  
 WT and LsATF4-KO mice were injected IP with 1 mg/kg tunicamycin or 
vehicle for 6 hours and total RNA was prepared with TRIzol reagent (Life 
Technologies, Grand Island, NY) following the manufacturer’s instructions by our 
collaborators at Rutgers University.  RNA sequencing was performed using an 
Illumina HiSeq2000 at Columbia University (Sulzberger Genome Center), with 
single-end reads and a read length of 100 base pairs.  Real-Time Analysis (RTA) 
was used for base-calling.  Fastq files were mapped to the mouse genome 
(NCBI37/mm9) using TopHat (v2.0.4).  Mapped reads were then assembled via 
Cufflinks (v2.0.2) with the default settings.  Assembled transcripts were then 
merged using the Cuffmerge program with the reference genome.  Analysis of 
mRNA levels was carried out using the Cuffdiff program, with samples being 
grouped by treatment condition, giving 4 conditions and 3 replicates per group.  
Samples were considered if they demonstrated a fold change between WT NT 
and WT Tm of 1.5 or greater, and if their q-value, a False Discovery Rate (FDR) 
adjusted p-value with FDR set at 0.05, was less than or equal to 0.05.  Venn 
diagrams were created with the use of a Venn diagram program (Venny 2.0.2) 
available at the following link (http://bioinfogp.cnb.csic.es/tools/venny/).  RNA-
Seq data are deposited in Gene Expression Omnibus (www.ncbi.nlm.gov/geo/) 
under the series number (GSE76771).   
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2.9 PANTHER Overrepresentation Test 
 PANTHER overrepresentation test (http://pantherdb.org/) compares the 
input gene list against a reference list.  A list of genes altered by the loss of ATF4 
under basal and stress conditions were used as inputs.  The reference list 
consisted of the PANTHER-GO list of mouse genes.  Lists of genes targeted by 
ATF4 were then subdivided by the same categories as the PANTHER list, on the 
basis of GO classification, and then a binomial test was performed to determine 
overrepresentation of the user list of genes compared to expected number of 
genes if occurring at random.  Results were evaluated with a Bonferroni 
corrected p-value.  P-values less than 0.05 were considered significant. 
 
2.10 Generation of Volcano Plots  
 Results from the RNA-Seq analysis for each condition comparison; WT 
NT to Tm, WT NT to LsATF4-KO NT, and WT Tm to LsATF4-KO Tm were read 
into R studio.  The fold change and q-value for each gene were then represented 
on a volcano plot using the code listed in Table 2-2.  R (v3.1.1) was used with the 
only additional library required being the calibrate library.  Images were then 
transferred into Adobe Illustrator for editing. 
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Table 2-2. Code for Generation of Volcano Plots 
Volcano2NoLabLeg <- function(filename, Treatment) { 
  rna <- read.table(filename, header = TRUE, fill = TRUE) 
  rna2 <- transform(rna, log10pvalue = -log10(p_value)) 
  with(rna2, plot(log2.fold_change., log10pvalue, pch =20, col = rgb(0,0,0,alpha = 
0.2))) 
  with(subset(rna2, q_value<0.05), points(log2.fold_change., log10pvalue, pch = 
20, col = rgb(1,0,0,0.2))) 
  with(subset(rna2, abs(log2.fold_change.)>0.5), points(log2.fold_change., 
log10pvalue, pch = 20, col = rgb(0,0.39,0,0.2))) 
  with(subset(rna2, q_value<0.05 & abs(log2.fold_change.)>.5), 
points(log2.fold_change., log10pvalue, pch = 20, col = rgb(1,0.84,0,0.2))) 
  with(subset(rna2, q_value<0.05 & abs(log2.fold_change.)>.5 & gene == "Ddit3"), 
points(log2.fold_change., log10pvalue, pch = 18, col = "Black")) 
  with(subset(rna2, q_value<0.05 & abs(log2.fold_change.)>.5 & gene == "Atf4 "), 
points(log2.fold_change., log10pvalue, pch = 15, col ="Black")) 
  with(subset(rna2, q_value<0.05 & abs(log2.fold_change.)>.5 & gene == "Asns"), 
points(log2.fold_change., log10pvalue, pch = 17, col = "Black")) 
} 
 
 
2.11 Lipid Peroxidation measurements 
 The Lipid Peroxidation (MDA) Colorimetric/Fluorometric Assay from 
BioVision (BioVision, Milpitas, CA) was used to measure the natural by-product 
of lipid peroxidation malondialdehyde (MDA).  Liver tissue was obtained from 
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LsPERK-WT, LsPERK-KO, LsATF4-WT, and LsATF4-KO mice that were treated 
with 0.3% DMSO or 1 mg/kg tunicamycin for 24 hours prior to livers being 
collected. 10 mg of liver tissue or cell culture was prepared in MDA lysis buffer 
and then sonicated prior to centrifugation.  Cell lysate protein was calculated via 
Lowery assay to allow normalization of samples per mg of protein used. The 
MDA-TBA adduct was colorimetrically detected at (λ = 532nm), and the MDA 
concentration was adjusted according to the mass of liver tissue used for each 
sample and the standard curve based on a provided MDA standard prepared in 
serial dilutions.  Samples were measured on a Synergy H1 (BioTek, Winooski, 
VT) fluorescence microplate reader. 
 
2.12 Measurements of Mitochondrial Membrane Potential 
 15,000 Hepa1-6 shCtrl and Hepa1-6 shATF4 cells were plated per well in 
a 96 well plate.  Cells were treated with vehicle or 2 μM rotenone for 6 hours.  
The media was removed and 100 μl of Mitotracker Red (ThermoFisher, Waltham, 
MA) was added to serum free DMEM plus 10 μg/ml Hoechst stain 
(ThermoFisher, Waltham, MA).  The cells were incubated at 37°C for 1 hour, 
prior to removing the probes and washing twice with DMEM.  The cells were then 
imaged using spinning disk confocal microscopy using Opera (PerkinElmer, 
Waltham, MA) and quantified using the program Columbus as previously 
described [89]. 
 
2.13 Luciferase assays  
34 
 Luciferase assays were carried out in six-well plates with the Dual-
Luciferase reporter assay system according to the manufacturer’s instructions 
(Promega, Madison, WI).  The plasmid p5XATF6GLC3 used for measuring ATF6 
activity plasmid was provided by Dr. Ron Prywes (Columbia University) and was 
previously described [92].  This reporter contains five ATF6 binding elements 
integrated into a promoter adjoined to the firefly luciferase reporter gene and was 
cotransfected into Hepa1-6 cells, along with a Renilla expressing plasmid for 
normalization.  Measurements were determined as the relative light units (RLU) 
of the firefly luciferase to the Renilla luciferase.   
 
Table 2-3.  Plasmids used in this study 
WB 
ID# 
Description Source 
912 5X ATF6 in pGL3 luciferase.  Contains 5 optimized ATF6 
binding elements in tandem.   
Prywes 
984 pMDLg/pRRE Lenti (packaging)  from Addgene 3rd 
generation plasmids, AmpR 
Cornetta 
985 pRSV-REV Lenti(packaging) from Addgene 3rd generation 
plasmids, AmpR 
Cornetta 
986 pVSV-G Lenti (envelope) from Addgene 3rd generation 
plasmids, AmpR 
Cornetta 
1175 shRNA Control, AmpR Quilliam 
1180 shRNA mATF4 TRC identifier (last 2-digits) #26, AmpR Sigma-
Aldrich 
1181 shRNA mATF4 TRC identifier (last 2-digits) #27, AmpR Sigma-
Aldrich 
1162 shRNA mATF5 TRC identifier (last 2-digits) #56, AmpR Sigma-
Aldrich 
1164 shRNA mATF5 TRC identifier (last 2-digits) #53, AmpR Sigma-
Aldrich 
1173 shRNA mATF6 TRC identifier (last 2-digits) #26, AmpR Sigma-
Aldrich 
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1174 shRNA mATF6 TRC identifier (last 2-digits) #28, AmpR Sigma-
Aldrich 
1246 shRNA mCHOP TRC identifier (last 2-digits) #09, AmpR Sigma-
Aldrich 
1247 shRNA mCHOP TRC identifier (last 2-digits) #77, AmpR Sigma-
Aldrich 
 
 
2.14 Cell Survival Assays 
 The Calcein AM Viability Dye (eBioscience, San Diego, CA) was used to 
measure cell survival.  This assay was performed in 96 well plates and evaluated 
according to manufacturer’s instructions using a Synergy H1 (BioTek, Winooski, 
VT) reader with an excitation wavelength of 495 nm and emission detection at 
515 nm.  5x103 cells were cultured in DMEM supplement with 10% FBS, 
penicillin (100 IU/ml), and streptomycin (100 μg/ml) in a final concentration of 2 
μM tunicamycin, 1 μM MG132, or no stress agent for 24 hours.  Calcein-AM dye 
was then added for 30 minutes at room temperature prior to measuring 
fluorescence.  The Caspase 3/7 kit was carried out using the Caspase-Glo 3/7 kit 
(Promega, Madison, WI) that was performed in 96 well plates, as previously 
described [93].  Briefly, livers were homogenized in a hypotonic extraction buffer 
(25 mM HEPES (pH 7.5), 5 mM MgCl2, 1 mM EGTA, 1 mM PMSF, and 1 μg/ml 
of aprotinin, leupeptin, and pepstatin).  The liver lysates were then clarified by 
centrifugation at 13,000 x g for 30 minutes at 4 °C.  Equal volumes of the diluted 
extracts (10 μg/ml) and Caspase-Glo reagent were used in the 96 well plates, 
prior to 1-hour incubation at room temperature.  Results were then read using a 
Synergy H1 plate reader. 
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2.15 Statistics   
 All data are shown as the mean ± SD and were derived from at least 3 
independent experiments.  Statistical significance was determined using th two-
tailed Student’s t-test.   
Multiple testing between groups was assessed using a two-way analysis 
of variance to determine the significance of the interaction between the groups.  
The “*” indicates statistical significance (p <0.05) with respect to the treated 
samples between the two cell types.  The “#” highlights statistical significance (p 
< 0.05) with respect to the untreated samples between the two cell types.  The 
“$” indicates statistical significance (p < 0.05) between untreated sample 
compared to ER stress for each cell type.   
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CHAPTER 3.  RESULTS: THE ISR IS REQUIRED FOR ATF6 ACTIVATION 
3.1  UPR signaling differs between cell culture models 
UPR studies featuring MEF cells subjected to pharmacological induction 
of ER stress indicated that ATF4 directs transcriptional expression of genes 
involved in amino acid metabolism, oxidative stress reduction, and control of 
apoptosis [6].  To address the role of ATF4 in the UPR in hepatocytes, we 
depleted ATF4 expression in the mouse hepatoma cell line Hepa1-6 using 
shRNA and compared the induction of key UPR genes with that of MEF cells 
deleted for ATF4 (Figure 3-1, A-D).  There was a significant reduction in ATF4 
mRNA and protein in the shATF4 cells compared to control after 3 or 6-hour 
treatment with 2 μM tunicamycin (Tm), an inhibitor of N-glycosylation of proteins 
in the ER and potent inducer of ER stress (Figure 3-1, C and D).  Known ATF4-
target genes involved in amino acid metabolism, including ASNS and FGF21, 
were also found to be reduced in the Hepa1-6 cells [43, 48, 94, 95].  Hepa1-6 
and MEF cell lines both demonstrated the expected increased levels of ASNS, 
FGF21, and CTH mRNAs in response to Tm, and this induction was significantly 
ablated upon loss of ATF4 (Figure 3-1, A and C).  Basal levels of genes were 
also significantly reduced upon the loss of ATF4.  Differences in the gene 
transcripts between ATF4 loss and treatment were found to be significant by two-
way ANOVA (p < 0.05).  Emphasizing the importance of cross-regulation in the 
UPR, ATF4 was also required for full induction of XBP1t mRNA and its spliced 
variant XBP1s during ER stress (Figure 1, A and C).  In both MEF and Hepa1-6 
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cell lines, two-way ANOVA demonstrated statistical significance for the 
interaction between treatment and presence or depletion of ATF4 expression.  
Our comparison between ATF4-directed gene expression in Hepa1-6 and 
MEF cell lines also showed key differences between the two cell types.  ATF4 is 
required for full cleavage to the active N-terminal version ATF6(N) in MEF cells 
treated with Tm [25].  As previously shown, the loss of ATF4 in the MEF cells led 
to a reduction in full-length ATF6 protein by 67% at 6 hours, with a more 
pronounced 97% reduction of ATF6(N) (Figure 3-1B).  However, the role of ATF4 
in the activation of ATF6(N) was much diminished in Hepa1-6 cells (Figure 3-1D).  
In the case of SOD2, encoding superoxide dismutase 2 that serves to clear ROS 
from mitochondria, deletion of ATF4 in MEF cells led to higher levels of SOD2 
mRNA in both basal and ER stress conditions, whereas loss of ATF4 expression 
in Hepa1-6 cells led to a substantial lowering of SOD2 transcripts in either 
stressed or non-stressed conditions.   
Given the reported anti-oxidation role of ATF4 in MEF cells [6], we also 
addressed whether there was generation of oxidative stress in the Hepa1-6 cells 
upon loss of ATF4.  We assessed the oxidation status in shATF4 and control 
cells by measuring malondialdehyde (MDA), which is generated by lipid 
peroxidation.  Lipid peroxidation occurs when free radicals remove electrons from 
lipids [96].  Loss of ATF4 results in cellular damage [6].  MDA occurs as a natural 
by-product of the reaction, making it an effective marker of lipid peroxidation [96].  
Depletion of ATF4 in Hepa1-6 cells grown in DMEM, which features high levels 
of glucose, did not affect the accumulation of MDA (Figure 3-1E).  We also 
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examined mitochondrial function by using the Mito Tracker Red assay to 
measure mitochondrial membrane potential.  There was over a 2-fold reduction 
in the mitochondrial potential upon depletion of ATF4, which was similar to the 
lowered levels generated by treatment with rotenone, a potent inhibitor of 
mitochondrial respiration, which functions by inhibiting the transfer of electrons 
from complex 1 to ubiquinone (Figure 3-1F).   
CHOP is considered to be a canonical downstream effector of the 
PERK/ATF4 pathway and as expected, we observed a sharp increase in CHOP 
mRNA and protein levels in MEF cells treated with Tm, which was significantly 
lowered upon deletion of ATF4 (Figure 3-1, A and B).  However in Hepa1-6 cells 
the substantial increase in CHOP transcripts observed during ER stress was only 
modestly lowered upon depletion of ATF4, and there was full induction of CHOP 
protein even with depleted ATF4 expression (Figure 3-1, C and D).  These 
results suggest that many features of the UPR gene expression networks 
described in MEF cells cannot be applied to every cell type and that UPR 
regulators other than ATF4 can contribute to CHOP expression. 
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Figure 3-1. Hepa1-6 cells demonstrate an ATF4-Independent CHOP 
expression. (A) WT and ATF4-/- MEF cells were treated with 2 μM tunicamycin 
(Tm) for 6 hours, or no stress treatment (NT) and levels of ATF4, CHOP, FGF21, 
ASNS, CTH, SOD2, XBP1t, and XPB1s mRNAs were determined by qPCR.  (B) 
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WT and ATF4-/- MEF cells were treated with 2 μM Tm for 3 or 6 hours and ATF4 
and CHOP levels were evaluated by immunoblot analyses using specific 
antibodies. Levels of the indicated mRNAs (C) and proteins (D) were measured 
in Hepa1-6 shCtrl and Hepa1-6 shATF4 cells by qPCR and immunoblot 
analyses, respectively.  (E) MDA analyses on Hepa1-6 shCtrl and shATF4 cells 
were examined using the BioVision Lipid Peroxidation kit.  (F) Hepa1-6 and 
Hepa1-6 shATF4 cells were plated on glass bottom plates, and then evaluated 
using Mitotracker Red. Image of the red-fluorescent dye that stains mitochondria 
in live cells are shown in the top panel and quantitation are indicated by 
histograms in the bottom panel.  The“*” indicates statistical significance (p <0.05) 
with respect to the treated samples between the two cell types.  The “#” 
highlights statistical significance (p < 0.05) with respect to the untreated samples 
between the two cell types.  The “$” indicates statistical significance (p < 0.05) 
between untreated sample compared to ER stress for each cell type. 
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3.2  Liver cell culture requires ATF6 for optimal CHOP expression 
A previous study of CHO and COS-1 cell lines suggested that ATF6 can 
contribute to CHOP expression by an Endoplasmic Reticulum Stress Response 
Element (ERSE) situated in the CHOP promoter [53].  We addressed the role 
played by ATF6 in CHOP expression in Hepa1-6 cells by depleting ATF6 using 
shRNA, followed by treatment with 2 μM Tm.  Loss of ATF6 led to reductions in 
the expression of well-defined ATF6-target genes, including ER chaperone BiP 
(GRP78/HSPA5) and XBP1t and its spliced variant XBP1s (Figure 3-2A) [15, 97].  
The interaction between loss of ATF6 and treatment was found to be significant 
by two-way ANOVA for all three genes.  ATF4 mRNA levels were also modestly 
reduced in the ATF6-depleted cells treated with Tm, but there was no 
measurable reduction in ATF4 protein levels (Figure 3-2, A and B).  Of 
importance, depletion of ATF6 sharply lowered the induction of CHOP mRNA 
and protein upon ER stress in the Hepa1-6 cells. CHOP protein levels were 
reduced by 76% and 51% at 3 and 6 hours, respectively.  These results suggest 
that ATF6 can be a major contributor to CHOP expression, especially during ER 
stress.  To address whether other ATF transcription factors regulated by PERK 
can also effect CHOP expression, we depleted ATF5 expression in Hepa1-6 cells 
using shRNA and found no changes in induced expression of CHOP protein by 
ER stress (Figure 3-2C).  These findings indicate that the requirement of ATF6 
for induced CHOP expression in the Hepa1-6 hepatocytes is not broadly shared 
between other transcription factors, such as ATF5, which are controlled by 
PERK. 
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CHOP can direct the expression of genes involved in protein homeostasis, 
in particular, those promoting protein folding, such as HSPA1B and DNAJ4, and 
a number of aminoacyl tRNA-synthetases, including WARS [51, 54, 55, 98].  By 
contrast during prolonged ER stress triggered by pharmacological agents, CHOP 
can instead trigger cell death through the expression of pro-apoptotic genes 
such, as BIM or GADD34 [51, 55, 98-100].  We wished to determine whether 
depletion of the upstream regulators ATF6 or ATF4 altered Hepa1-6 survival 
upon treatment with either Tm or another stress agent, the proteasome inhibitor 
MG132.  As expected, in Hepa1-6 cells depletion of CHOP showed protective 
effects upon either stress treatment as judged by lowered calcein-AM labeling 
(Figure 3-2D).  Lowered expression of either ATF4 or ATF6 led to significant 
increases in cell death upon ER stress, 20%, and 15% respectively, compared to 
control cells.  These findings are consistent with the protective effects attributed 
to the ATF4 and ATF6 transcription factors in the UPR [6, 21]. 
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Figure 3-2.  ATF6 facilitates induced CHOP expression in liver cells 
subjected to ER stress.  (A) Hepa1-6 shCtrl and Hepa1-6 shATF6 cells were 
treated with 2 μM tunicamycin (Tm) for 6 hours, or no stress treatment (NT), and 
the levels of ATF4, CHOP, ATF6, XBP1t, XBP1s, and BiP mRNAs were 
determined by qPCR.  (B) Hepa1-6 shCtrl and Hepa1-6 shATF6 cells were 
treated with 2 μM Tm for 3 or 6 hours and ATF4, ATF6, and CHOP levels were 
evaluated by immunoblot analyses.  CHOP levels were quantified using ImageJ 
based on three independent experiments for the 3 and 6 hour time points.  (C)  
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Hepa1-6 shCtrl and Hepa1-6 shATF5 cells were treated with 2 μM Tm for 3 or 6 
hours and levels of ATF5 and CHOP proteins were measured by immunoblot 
analyses.  (D) Hepa1-6 shCtrl, shATF4, shATF6, and shCHOP cells were treated 
with 2 μM Tm or 1 μM MG132 for 24hrs, or no stress treatment.  Cell proliferation 
was analyzed via Hoechst fluorescence, and cell death was measured by calcein 
fluorescence.   The “*” indicates statistical significance (p <0.05) with respect to 
the treated samples between the indicated cell types, and “#” indicates with 
respect to the untreated samples between the cell types.  
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3.3  Both ATF4 and ATF6 drive CHOP expression during nutritional 
stress 
We next addressed whether ATF4 and ATF6 contribute to CHOP 
expression in response to a stress that does not directly perturb the ER.  
Halofuginone (HF) has been previously shown to deplete charging of tRNAPro, 
leading to activation of GCN2, another eIF2 kinase, which can, in turn, enhance 
the transcriptional and translational expression of ATF4 and CHOP [101, 102].  
Treatment of Hepa1-6 cells with 50 nM HF for 6 hours led to significant increases 
in ATF4 and CHOP mRNAs and proteins (Figure 3-3, A-C).  Loss of either ATF6 
or ATF4 substantially lowered both CHOP mRNA and protein (Figure 3-3, A-C).  
Expression of GADD34 mRNA and protein was largely dependent on ATF4, with 
further increases in GADD34 induction upon depletion of ATF6.  It is noted that 
despite there being robust eIF2α-P and induction of ATF4, CHOP, and GADD34 
mRNAs in response to HF, the increase in ATF4, CHOP, and GADD34 proteins 
were reproducibly less than Tm treatment (Figure 3-1C).  This difference in the 
levels of induced CHOP and ATF4 proteins may be a consequence of the 
diminished Pro-tRNAPro available for protein synthesis during HF treatment.   
Consistent with the idea that the treatment regimen of HF did not elicit ER 
stress, there was no increase in the levels of XBP1t mRNA, and the amount of 
XBP1s transcripts were in fact substantially lowered in shCtrl Hepa1-6 cells 
exposed to HF.  ATF6 was suggested to contribute to CHOP expression, and 
there was a 3-fold increase in ATF6 mRNA levels during HF treatment.  While we 
did not measure appreciable activated ATF6(N) protein upon HF treatment by 
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immunoblot analyses, there was a 2-fold increase in ATF6-directed transcription 
as measured by a luciferase reporter assay, which was significant although 
diminished compared to ~15-fold enhancement during Tm treatment (Figure 3D). 
These results suggest a model where nutrient stress afflicting the cytosol induces 
both ATF4 and ATF6 to contribute to increased CHOP expression.  By 
comparison, ER stress triggers a pathway that is largely dependent upon ATF6 
for CHOP expression (Figure 3-3E). 
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Figure 3-3.  ATF6 contributes to CHOP expression in multiple stresses. 
Hepa1-6 cells expressing shCtrl, shATF6, or shATF4, were treated with 2 μM 
tunicamycin (Tm) or 50 nM halofuginone (HF) for 6 hours or no stress treatment 
(NT), as indicated.  (A, B) Levels of the indicated gene transcripts were 
measured by qPCR.  (C) The amounts of the indicated proteins were measured 
by immunoblot analyses.  (D) Hepa1-6 cells were co-transfected with 5x ATF6 
Binding Element Luciferase construct and Renilla.  After 24 hours, cells were 
treated with 2 μM Tm or 50 nM HF, prepared and firefly luciferase normalized for 
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Renilla were measured for prepared lysates.  (E) Model of the roles of ATF4 and 
ATF6 on the expression of CHOP during ER stress and cytosolic stress triggered 
by HF treatment.  The “*” features statistical significance (p <0.05) between ER 
stress-treated cells.  The “#” indicates significance (p < 0.05) of untreated cells, 
and “$”significance (p < 0.05) of untreated cells. 
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3.4  Comparison of ATF4 and ATF4/CHOP target genes in ATF4 knockout 
mouse 
The identification of ATF4-independent induction of CHOP expression in 
Hepa1-6 cells subjected to ER stress raises the question of whether this pattern 
of gene expression is physiologically relevant in vivo.  We initially characterized 
whole body ATF4-depleted mice (WbATF4-KO), but the breeding of these 
animals can be problematic as reported [78] and we subsequently extended our 
analyses to mice with a liver-specific ATF4 deletion (LsATF4-KO).  Mice 
expressing Cre from the albumin promoter were bred to ATF4 gene floxed mice 
in a manner similar to the liver-specific PERK knockout that our laboratories have 
previously described [25].  WbATF4-KO (Figure 3-4) and LsATF4-KO mice 
(Figure 3-5), and their wild-type (WT) controls were treated with 1 mg/kg Tm or 
0.3% DMSO vehicle administered via an intraperitoneal (IP) injection for 6 hours.  
As expected ATF4 mRNA and protein were induced upon Tm treatment in WT 
livers, and ATF4 was minimally expressed in either knockout model (Figure 3-4, 
A and E and 3-5, A and E).  Consistent with the loss of ATF4 transcriptional 
activity, there was significant lowering in the expression of ATF4-target genes 
ASNS, FGF21, and CTH in the WbATF4-KO and LsATF4-KO livers (Figures 3-4, 
B and D and 3-5, B and D).  Two-way ANOVA analysis indicated significance 
between the treatment and mouse model for ASNS and FGF21 but did not 
achieve significance for CTH.  This would indict the response for CTH is 
dependent upon the loss of ATF4 within the basal state.  
51 
We next addressed the requirement for ATF4 for in vivo induction of key 
UPR gene markers.  Activation of ATF6(N) protein in the liver during ER stress 
was largely independent of ATF4 function, and there was only modest lowering 
of induced ATF6 mRNA in LsATF4-KO compared to WT (Figure 3-4, A and E 
and 3-5, A and E).  Levels of ATF6 mRNA in the WbATF4-KO were statistically 
indistinguishable.  Of importance, there was only minimal lowering of induced 
CHOP mRNA upon ER stress in either model of ATF4 depletion and full 
induction of CHOP protein independent of ATF4 function.  Expression at WT 
levels of ATF6 and CHOP can also be seen in the heterozygous mice for the 
ATF4-KO (Figure 3-4E).  Transcriptional expression of GADD34 and ATF5 are 
dependent on both CHOP and ATF4, and consistent with retention of CHOP 
function in the ATF4 knockout models, there was a partial induction of GADD34 
and ATF5 mRNAs compared to WT (Figure 3-4C and 3-5C). Together, these 
results are similar to our analyses with Hepa1-6 hepatoma cells and suggest that 
in the liver CHOP and ATF6 expression are uncoupled from ATF4 transcriptional 
responsibilities in the UPR.  Of importance, reported microarray analyses of 
livers prepared from WT and ATF6α-/- mice showed that loss of ATF6 
significantly lowered CHOP mRNA expression basally and upon IP injection with 
Tm for 8 hours [21] (Figure 3-4F), a finding consistent with our UPR analyses in 
Hepa1-6 cells (Figure 2A).  
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Figure 3-4.  CHOP expressed independent of ATF4 in WbATF4-KO mice.  
WT and WbATF4-KO were injected IP with 1 mg/kg body weight tunicamycin 
(Tm) or vehicle indicating no treatment (NT) for 6 hours.  (A-D) Livers were 
collected and mRNA levels were measured by qPCR for the indicated genes.  (B) 
ASNS and FGF21 represent ATF4-target genes.  (C) GADD34 and ATF5 
highlight genes regulated by both ATF4 and CHOP.  (D) CTH and SOD2 were 
analyzed to assess genes involved in mitochondrial function and oxidative stress.  
(E) The indicated proteins were measured by immunoblot analyses using lysates 
prepared from livers derived from mice treated with DMSO (-) or Tm (+) for 6 
hours.  (F) Measurement of mRNAs from microarray data derived from livers of 
whole body ATF6 knockout mice and their WT littermates [21].  The “*” indicates 
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statistical significance (p <0.05) among ER stress treated livers. “#” indicates 
statistical significance (p < 0.05) among untreated liver tissues, and “$” 
significance (p < 0.05) with respect to the untreated and treated tissues. 
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Figure 5.  CHOP is expressed independent of ATF4 in LsATF4-KO mice.  
WT and LsATF4-KO were injected IP with 1 mg/kg body weight tunicamycin (Tm) 
or vehicle indicating no treatment (NT) for 6 hours.  (A-D) Livers were collected 
and mRNA levels for the indicated genes were measured by qPCR.  (B) ASNS 
and FGF21 are indicated ATF4-target genes, (C) GADD34 and ATF5 highlight 
genes regulated by both ATF4 and CHOP.  (D) CTH and SOD2 mRNAs were 
analyzed to assess genes involved in mitochondrial function and oxidative stress.  
(E) Immunoblot analyses of the indicated proteins were carried out in livers 
obtained from mice treated with DMSO (-) or Tm (+) for 6 hours.  (F) Liver 
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samples from WT and LsATF4-KO mice treated with Tm for 24 hours were 
compared for levels of MDA via fluorescence using the Lipid Peroxidation Kit 
from BioVision.  (G) LsPERK-WT, LsPERK-KO, LsATF4-WT and LsATF4-KO 
mice were treated with IP injection of 1 mg/kg Tm or vehicle for 24 or 36 hours 
and caspase 3/7 activity was measured.  Histological samples were also 
assessed for TUNEL positive cells after 36 hours of Tm treatment, and the 
presented results are the average counts of 8 different histological sections.  The 
“*” indicate statistical significance (p <0.05) among cells subjected to ER stress, 
“#” features significance among untreated cells, and “$” with respect to the 
untreated compared to treated tissues. 
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3.5  Loss of ATF4 promotes oxidative stress and modest increase in cell 
death 
As previously seen in the Hepa1-6 shATF4 cell line, expression of CTH 
and SOD2 mRNAs were also reduced in the absence of ATF4 in the mouse 
models (Figure 3-4D and 3-5D).  LsATF4-KO mice also displayed elevated levels 
of MDA independent of stress (Figure 3-5F).  Of importance, this resistance to 
oxidative stress in vivo can be conferred by basal expression of ATF4, and this 
protection can occur independent of PERK as the LsPERK-KO did not show 
significant differences in MDA levels compared to WT.  
LsPERK-KO livers were previously shown to trigger cell death during 
extended periods of ER stress [25].  There was increased caspase 3/7 cleavage 
activity in LsPERK-KO mice upon treatment with 1 mg/kg Tm for 24 or 36 hours 
(Figure 3-5G).  By comparison, LsATF4-KO livers showed no change in the 
caspase activity compared to WT.  Livers prepared from LsPERK-KO treated 
with Tm also exhibited a robust increase in TUNEL positive cells, whereas 
LsATF4-KO showed a more moderate, but significant 10x increase compared to 
WT (Figure 3-5G).  These results indicate that PERK provides robust protection 
of livers exposed to ER stress, whereas ATF4 plays a more moderate role.   
 
3.6  RNA-Seq analysis of LsATF4-KO mice and ATF4 transcriptional 
subset 
 
To address the role of ATF4 in the genome-wide regulation of the UPR 
transcriptome, we carried out RNA-Seq analysis using livers prepared from WT 
and LsATF4-KO mice treated with 1 mg/kg Tm or vehicle for 6 hours.  The RNA-
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Seq featured single-end RNA sequencing with 100 base pair reads; 
approximately 32 million reads were collected for each mouse, with three animals 
per group.  Reads were mapped to the mouse mm9 genome using TopHat [103, 
104], and expression levels were characterized using Cufflinks, Cuffmerge, and 
Cuffdiff [104, 105].  Results were first analyzed by a volcano plot comparing the 
log2 of fold change to the -log10 of the q-value (Figure 3-6A).  There were 4717 
gene transcripts showing a significant change in WT liver upon ER stress (>1.5-
fold, p<0.05, FDR < 0.05), with 2271 genes showing an increase and 2446 a 
decrease in expression.  There were a total of 4364 genes showing a significant 
change in the LsATF4-KO liver upon ER stress.  3531 genes were altered upon 
ER stress in both WT and LsATF4-KO liver.  In order to examine genes whose 
expression was significantly different during stress, we compared WT Tm to 
LsATF4-KO Tm genes.  A total of 352 genes, or approximately 7.5% of the total 
UPR changes, were significantly affected by the loss of ATF4.   
Key UPR target genes ATF4, CHOP, and ASNS were each significantly 
induced in the WT liver (Figure 3-6A).  Consistent with our qPCR findings, the 
levels of ASNS, FGF21, and CTH were significantly lowered in the LsATF4-KO 
liver.  By comparison, induced CHOP expression was not significantly affected by 
the loss of ATF4 (Figure 3-6B).  The limited role of ATF4 in the UPR is 
noteworthy compared to our earlier genome-wide analysis that nearly 50% of the 
gene transcripts showing significant changes in liver exposed to Tm were 
dependent on PERK [25].   We conclude that ATF4 is required for induction of 
only a portion of PERK-dependent genes.  This finding suggests that there are 
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other PERK-driven events that are critical for regulation of the UPR-directed 
gene expression.   
It is noteworthy that many genes required ATF4 for full expression during 
basal conditions, suggesting that ATF4 plays a significant role in directing the 
transcriptome in seemingly non-stressed conditions in the liver.  There were 385 
genes that were altered by the loss of ATF4 during vehicle treatment.  Pathway 
analysis of ATF4-targeted genes using PANTHER was performed on gene 
expression with a significant q-value between WT and LsATF4-KO livers during 
either basal or ER stress conditions (Tables 3-1 and 3-2) [106, 107].  The 
analysis was performed by using the PANTHER statistical overrepresentation 
test, which involves comparing a user input list of genes against a reference list 
containing all genes.  These gene lists were then subdivided on the basis of GO 
classification, and a binomial test was then performed to determine 
overrepresentation of the users list of genes compared to the expected number if 
occurred by random.  Under basal conditions, several categories demonstrated 
greater than 5-fold enrichment, including those representing fatty acid 
biosynthetic processes and fatty acid metabolic processes (Table 3-1).   
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Table 3-1. Pathway analysis using PANTHER of altered genes in WT and 
LsATF4-KO livers during non-stressed conditions. 
 
 
During ER stress, we identified three pathways with fold enrichment 
greater than 5, including steroid biosynthetic process, cholesterol metabolic 
process, and sterol metabolic process (Table 3-2).  We also sought to further 
characterize the significant genes from our LsATF4-KO mice under basal and 
stress by comparing them to the ChiP-Seq data set, to generate altered genes 
that have been previously shown to be bound by ATF4 or ATF4 and CHOP [54].  
Genes that were found to be significantly altered in the basal or stress states 
were compared with genes which were found to be bound only by ATF4 or by 
both ATF4 and CHOP (Table 3-3).  We examined the expression levels of these 
ChIP-confirmed ATF4 targets in the absence of ATF4 via the RNA-Seq analysis.     
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Table 3-2.  Pathway analysis using PANTHER of regulated genes in WT and 
LsATF4-KO livers during treatment with tunicamycin. 
 
Table 3-3.  Comparison of altered gene expression in the absence of ATF4 in 
basal and stress states with genes bound by ATF4 or both ATF4 and CHOP.   
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Figure 3-6.  ATF4 is required for expression of a subset of UPR genes.  (A) 
RNA-Seq analyses measuring levels of gene transcripts from WT and LsATF4-
KO mice treated with 1 mg/kg tunicamycin (Tm) or vehicle (NT) for 6 hours.  
Volcano plot of WT NT versus Tm, and WT Tm versus LsATF4-KO.  (B) Levels 
of UPR gene transcripts by RNA-Seq analysis, which are organized into ATF4-
dependent groups (ASNS, FGF21, CTH, DDIT4, and CARS) and those genes 
bound by both ATF4 and CHOP (CHOP, ATF5, GADD34, TRIB3, and ATF6).   
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3.7  ATF4 facilitates the metabolism of cholesterol in the liver 
Given that the top three biological pathways affected during ER stress 
were centered on genes involved in sterol and cholesterol metabolism and 
SOAT2 was an ATF4 and CHOP target, we next experimentally addressed the 
effect of ATF4 loss on cholesterol.  Our RNA-Seq and PANTHER Pathway 
analysis suggested a role for ATF4 in the metabolism of cholesterol and related 
bile acids (Table 3-2 and Figure 3-7, A-D).  ATF4 was required for expression of 
several key genes involved in bile acid synthesis, which represents one pathway 
for disposing of free cholesterol in hepatocytes.  Among these synthetic genes, 
CYP7A1, encoding cholesterol 7 alpha-hydroxylase, and CYP27A1, encoding 
sterol 27-hydoxylase, were significantly lowered in LsATF4-KO cells in both basal 
and ER stress conditions (Figure 3-7, A and B).  Expression of HNF4α, a gene 
that enhances transcription of CYP7A1 [108, 109] was also significantly reduced 
in LsATF4-KO livers.  ATF4 is also required for full induction of SOAT2, which 
facilitates the conversion of free cholesterol to esterified cholesterol and was 
previously shown to be bound by ATF4 by ChiP-Seq (Figure 3-7, A and C) [54, 
110, 111].  Free cholesterol can be damaging to cells through activation of JNK 
signaling and impairment of mitochondria membrane fluidity, and injury can be 
prevented by cholesterol esterification [73, 112, 113].  nCEH1 was significantly 
reduced in response to ER stress independent of ATF4.  Expression of genes 
responsible for exporting free cholesterol was also altered in the LsATF4-KO 
mice.  ABCG5 and ABCG8 encode transporters that function on the enterocyte 
side of the hepatocyte, which export free cholesterol (Figure 3-7A) [114].  
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Expression of both genes were significantly reduced during ER stress, and loss 
of ATF4 further lowered the amounts of ABCG5 and ABCG8 mRNAs during 
basal conditions (Figure 3-7D).  ABCA1 encodes a transporter of free cholesterol 
from hepatocytes to the plasma, and consistent with a previous report [115] 
ABCA1 mRNA was reduced during ER stress.  Deletion of ATF4 decreased 
ABCA1 expression basally (Figure 3-7D) and was found to be further reduced 
upon stress, which was found to be significant by two-way ANOVA of the 
interaction between treatment and the loss of ATF4.  The key regulatory genes, 
SREBP1 and SREBP2, were however, unaffected by the loss of ATF4.  
Together, these findings suggest that ATF4 contributes to the expression of key 
genes involved in cholesterol metabolism and transport.  
We next determined whether there are changes in free cholesterol levels 
upon loss of ATF4 in response to ER stress.  There were lowered levels of serum 
cholesterol basally in the LsATF4-KO mice compared to WT (Figure 3-7E), a 
finding consistent with that reported for WbATF4-KO [116].  Furthermore, 
cholesterol was lowered in both WT and LsATF4-KO mice after treatment with 
Tm (Figure 3-7E).  While the LsATF4-KO mice trended towards lower total 
cholesterol during ER stress compared to WT, it did not reach statistical 
significance.  We also measured the levels of free and total cholesterol in liver 
tissue (Figure 3-7F).  Liver tissue from LsATF4-KO mice during stress showed 
significantly increased levels of free cholesterol, based on assays in the absence 
of esterase that represents free cholesterol.   
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Figure 3-7.  Loss of ATF4 leads to increased free cholesterol in liver.  (A) 
Illustration of ATF4-targeted gene functions in hepatocyte cholesterol 
metabolism.  (B) WT and LsATF4-KO mice were injected IP with 1 mg/kg 
tunicamycin (Tm) or vehicle (NT) for 6 hours.  (B-D) Levels of the indicated 
mRNAs were measured by qPCR and (E-F) cholesterol content by the Amplex 
Red Cholesterol assay kit.  (B-D) Genes involved in bile acid synthesis (CYP7A1, 
CYP27A1, HNF4α), cholesterol esterification (SOAT2), or cholesterol export 
(ABCA1, ABCG5, ABCG8) were significantly reduced due to loss of ATF4.  (D-E) 
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WT and LsATF4-KO livers treated with Tm or vehicle were analyzed for total 
cholesterol content in the serum (E) and within the tissue (F).  The “*” indicates 
statistical significance (p <0.05) with respect to the ER treated tissues, 
“#”significance (p < 0.05) among untreated tissues, and “$” highlights significance 
between respective untreated ER stress tissues. 
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3.8  ATF4 basal expression is required for lipid metabolism 
 Given that Hepa1-6 shATF4 cells demonstrated lowered mitochondrial 
membrane potential (Figure 3-1F), we proposed that genes whose expression 
were reduced in the basal state adversely affected the mitochondria.  Lipids play 
an important role in the structural integrity of the mitochondrial membrane, 
specifically the lipid cardiolipin, which is found almost exclusively in the 
mitochondria [117].  Cardiolipin is synthesized by the gene CRLS1, which was 
previously reported to be an ATF4-target gene by a genome-wide ChIP-Seq [54].  
Deletions of this gene ortholog in yeast impair the electron transport chain and 
cause a decrease in mitochondrial membrane potential [118].  CRLS1 is a 
member lipid metabolic process GO category identified by our PANTHER 
analysis of basal genes (Table 3-1) and demonstrated a significant reduction in 
expression in the RNA-seq.  qRT-PCR of WT and LsATF4-KO mouse liver 
samples under basal conditions confirmed this reduction in expression, 
demonstrating a ~40% reduction in CRLS1 mRNA expression (Figure 3-8A).  
This decrease was also seen at the CSRL1 protein level, where relative protein 
levels were reduced by ~50% (Figure 3-8B).  These results suggest that ATF4 
plays a direct role in the physiology of the mitochondria, and the energy 
production of the cell. 
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Figure 3-8. Loss of ATF4 leads to reduced CRLS1 expression. (A) WT and 
LsATF4-KO mouse livers were collected and analyzed via qRT-PCR for CRLS1 
gene expression.  (B) WT and LsATF4-KO mouse livers were collected and 
analyzed via immunoblot for expression of CRLS1.  The image is representative 
of three separate immunoblots.  Relative protein levels were assessed via 
ImageJ [90]. 
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CHAPTER 4.  DISCUSSION 
4.1  Similarities and differences in UPR signaling between cell culture 
models 
The principal findings and models regarding ATF4 and its role in the ER 
stress response in earlier publications have been based largely on findings from 
MEF cell lines, and our results suggest that there can be variations between cell 
culture lines, and between cell culture and in vivo, though the possibility of 3D 
culture effects may also play a role [6, 46].  While certain characteristics were 
shared between cultured MEF, Hepa1-6 cells, and liver in vivo, there were also 
striking differences.  Expression of ATF4 target genes ASNS, FGF21, and CTH 
were reduced upon loss of ATF4 regardless of the cell type studied (Figure 3-1, 
A and C).  In contrast to MEF cells, ATF4 was not required for induced CHOP 
mRNA and protein in the Hepa1-6 cell line (Figure 3-1, C and D).  ATF6 
expression was also unaffected by the loss of ATF4 in liver, in contrast to data in 
MEF cells (Figure 3-1B) [25].  Whether this response is specific to the liver or an 
adaptive response to the loss of ATF4, is yet to be determined and warrants 
future investigation.  ATF4 was previously suggested to play a role both in the 
transcription and transport of ATF6 in response to ER stress [25].  ATF4-/- MEFs 
fail to induce ATF6 mRNA in response to stress, yet the results from the Hepa1-6 
cell line would suggest that ATF4 does not play a major role in the transcription 
or transport of ATF6 (Figure 3-1B).  These findings suggest that there could be 
another activating factor, or the basal levels of ATF6 are sufficient to elicit 
downstream responses upon activation.  
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ATF4-/- MEF cells have been previously associated with increased cell 
death, and an increase in oxidative stress in the basal condition [59].  Hepa1-6 
cell lines that lacked ATF4 expression showed a similar increase in cell death in 
response to prolonged ER stress (Figure 3-2D).  The increase in cell death in 
these ATF4-/- cells is likely a consequence of lower expression of critical adaptive 
gene expression.  It is important to note that there was continued ATF4-
independent expression of the pro-apoptotic CHOP in the Hepa1-6 cells. This 
model of cell death would still vary from what is seen in MEF cell lines.  MEF 
cells devoid of ATF4 also lack expression of CHOP.  Thus, cell death is attributed 
to the lack of ATF4 pro-survival downstream targets, combined with lower CHOP.  
Differences in the mechanisms of cell death between the two cell lines are likely 
to depend on the presence or absence of oxidative stress.  In MEF cells lacking 
ATF4, oxidative stress was present in the basal state as assessed by increased 
cell survival upon the addition of reducing compounds, such as β-
mercaptoethanol [6], yet this oxidative stress was not present in the Hepa1-6 cell 
line model as measured by lipid peroxidation (Figure 3-1E).  This dissimilarity 
could result from the physiological differences between a liver-derived Hepa1-6 
cell line and the fibroblast-based MEF cells.  The difference between the Hepa1-
6 cell line, and LsATF4-KO mice may result from the media supplementation or 
represent a difference between culture and in vivo. 
 
4.2  Role of crosstalk in the UPR 
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In the Hepa1-6 cell line, ATF6 was found to be central to CHOP 
expression during ER stress (Figure 3-2, A and B).  In both in vivo and in-vitro 
models, PERK was shown to be required to elicit maximal expression of ATF6 
mRNA and activation of ATF6(N) [25].  These findings suggest a pathway for 
UPR activation that requires the PERK and ATF6 arms to elicit CHOP 
expression.  This crosstalk is further expanded to include a role for ATF6 in the 
induced expression of XBP1 mRNA (Figure 3-2A).  These mechanisms of cross-
talk imply that there are unique pathway functions in UPR activation rather than a 
system of redundancies.  If ATF6 activation in response to ER stress were 
merely redundant with the ATF4 for activation of CHOP, loss of ATF4 would still 
diminish expression of CHOP.  These unique activation pathways contributing to 
cross regulation of the UPR are also illustrated by the fact that ATF factors 
cannot replace each other, as illustrated by the finding that loss of ATF5 has no 
effect on CHOP expression, unlike the loss of ATF6 (Figure 3-2C).   
In contrast to ER stress, there is some overlap in the pathways that 
activate ATF4 in response to cytosolic stresses that induce eIF2α-P.  For 
example, induction of CHOP expression was dependent upon both ATF4 and 
ATF6 during HF treatment that inhibits tRNA charging in the cytosol.  This finding 
suggests that ATF4 is capable of driving CHOP expression within the liver, but 
this induction is dependent on the nature of the activating stress.  It is noteworthy 
that there is a more modest activation of ATF6 during HF exposure compared 
with Tm (Figure 3-2 A and B, Figure 3-3 A and C).  HF stress upregulates ATF6 
and ATF4 mRNA but leads to the repression of XBP1s mRNA, supporting the 
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role of HF role as a cytosolic stress that does not appear to disrupt the ER.  The 
lower level induced expression of ATF4 protein by HF also suggests that this 
stress activates the ISR to a lower extent than Tm treatment (Figure 3-3C).  
ATF6(N) protein expression was not detectable in the HF stress although CHOP 
mRNA levels would suggest that ATF6 still is a contributing activator.  This was 
further supported by the ATF6 activity reporter, which showed significant 
induction upon HF treatment (Figure 3-3D). 
ATF6 was previously shown to be a component of CHOP expression 
through an ESRE situated in its promoter [53].  The role of ATF6 has been 
overshadowed by the requirement in MEF culture cells on ATF4 binding to the 
amino acid response element (AARE) within the CHOP promoter [53, 119] and 
the idea that the three arms of the UPR operate independently.  This switch from 
ATF4 to ATF6 -dependent CHOP expression may result in part from the timing of 
activation, with activation of ATF6 preceding that of ATF4 or the differential 
availability of the binding partners for ATF4 and ATF6.  ATF6 is rapidly cleaved 
and activated upon ER stress, whereas ATF4 requires preferential translation 
and its induction occurs later in the UPR.  The basic leucine zipper structure of 
ATF6 results in a preference for homodimerization, while ATF4 does not 
demonstrate a preference between homo and heterodimerization [120].  Thus, 
ATF4 not only requires upregulation of its own translation but can also be 
influenced by the nature of its binding partner.  The timing may also explain why 
ATF5 does not play a role, unlike its other ATF family members ATF4 and ATF6.  
ATF5 is subject to preferential translational by a mechanism that is similar to 
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ATF4, and ATF5 has similar hetero- vs homo- dimerization preferences but 
requires ATF4 and CHOP for induction of its transcription [51, 120, 121].  The 
timing for induced ATF5 expression would therefore likely be too late for it to act 
as a primary driver of CHOP expression.  These findings support the idea that 
the PERK/ATF6 crosstalk is a primary driver of CHOP expression within the liver 
during ER stress (Figure 3-3E).  Furthermore, there is a network of feedforward 
transcriptional activation pathways that can rapidly amplify induction of the UPR 
transcriptome in response to an initiating ER insult. 
 
4.3  Role of ATF4 in the ER stress response in vivo 
Our RNA-Seq analysis suggests an expanded role for ATF4-directed gene 
expression in liver under apparent basal conditions.  385 genes were significantly 
altered by the loss of ATF4 in non-stressed conditions, which in fact exceeded 
those regulated during Tm treatment.  The ATF4-target genes expressed during 
basal conditions are represented by metabolic processes of fatty acids and 
steroids, and cell adhesion (Table 3-1).  ATF4 has previously been shown to 
promote metastasis in a tumor environment but is also required basally for the 
spread and progression of tumors [88].   
Deletion of ATF4 also significantly changed the expression of 352 genes 
among the set of 4717 genes altered during ER stress.  The unexpected small 
subset of genes requiring ATF4 in the UPR compared to those involving PERK 
emphasizes that PERK can facilitate multiple transcriptional control networks 
beyond ATF4, including those of ATF6 and XBP1 [25].  Additionally, ATF4 and 
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CHOP ChIP-Seq analysis indicated that induced CHOP can play a direct role in 
the expression of genes that are also targeted by ATF4 [54].  Thus, PERK may 
be able to alleviate the loss of ATF4 by exhibiting ATF4-independent expression 
of ATF6, ATF6-driven CHOP transcription, and CHOP upregulation of particular 
genes during ER stress.   
Deletion of ATF4 in liver further demonstrates its role in the prevention of 
oxidative stress independent of ER stress (Figure 3-5F).  It is noted that there 
was no difference in MDA levels in cultured Hepa1-6 cells compared to those 
depleted for ATF4 (Figure 3-1E).  Loss of ATF4 in the Hepa1-6 cells did lead to a 
striking reduction in mitochondrial membrane potential (Figure 3-1F), and 
diminished ROS production via oxidative phosphorylation may help explain the 
absence of observed oxidative stress in Hepa1-6 cells depleted for ATF4.  
Rapidly proliferating cells cultured in high media glucose concentration can 
proceed by aerobic glycolysis [122].  It was reported that ATF4 contributes to 
increased H2S sulfhydration of certain metabolic proteins during ER stress, 
altering their activity [123].  H2S sulfhydration occurs on several proteins within 
glycolysis and the TCA cycle, leading to an increase in glycolysis and a decrease 
in oxidative phosphorylation, which can be restored through CTH inhibition, 
which is in some manner mimicked by the loss of ATF4 [123].   
 
4.4  ATF4 and cholesterol metabolism 
Our biochemical and RNA-Seq analysis established the importance of 
ATF4 in the expression of genes important in cholesterol metabolism and 
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transport (Figure 3-7, B-D).  Loss of ATF4 led to decreased expression of 
SOAT2, a gene that was also identified as an ATF4 and CHOP target by ChIP-
Seq analyses (Table 3-1) [54], suggesting a lowered conversion of free 
cholesterol to cholesterol esters in the livers of LsATF4-KO mice (Figure 3-7, A 
and C).  Free cholesterol would also be converted to bile acids at a reduced rate 
in the ATF4-deleted livers due to reduced expression of genes encoding 
CYP7A1 and CYP27A1 (Figure 3-7B).  It would be expected that export of free 
cholesterol would be adversely affected in LsATF4-KO mice (Figure 3-7A).  
Previous studies suggested that ER stress results in ~50% reduction in ABCA1 
mRNA levels and decreased plasma cholesterol concentration [115, 116].  We 
determined that deletion of ATF4 leads to a similar 50% reduction in ABCA1 
mRNA basally, which is further reduced by stress (Figure 3-7D).  We also 
showed that ER stress triggered decreased sera cholesterol, which is further 
lowered both basally and during stress upon loss of ATF4 (Figure 3-7E).  
Changes in gene expression and cholesterol levels may be a direct consequence 
of ATF4 transcriptional regulation or indirect through downstream UPR effectors.  
Collectively these ATF4-directed changes in expression of genes involved in 
cholesterol metabolism and transport help explain the increased free cholesterol 
load within liver tissues of the LsATF4-KO mice (Figure 3-7F).  Control of 
cholesterol metabolism via ATF4 in the basal and ER stress state coincides with 
the protective role of ATF4.  ATF4 control of SOAT2 expression allows cells to 
maintain appropriate levels of the potentially harmful free cholesterol, yet still 
allow for the conversion to bile acid [113].  Further investigation will be required 
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to delineate the direct roles of ATF4 in the metabolism of cholesterol.  Currently, 
SOAT2 is the only known direct target of ATF4 in cholesterol metabolism, 
although the RNA-Seq analysis presented herein would suggest that there are 
others.  The seemingly contradictory activation of SREBP and its transcriptional 
repression during ER stress could be suggested to allow for temporary alleviation 
of ER stress through ER expansion.  The transcriptional repression of SREBP1 
then would prevent further accumulation of lipids, as a result of de novo 
synthesis, alleviating a potential further stressor. 
 
4.5  Role of ATF4 in gene expression during the basal state 
Loss of ATF4 and the subsequent reduction in mitochondrial membrane 
reduction suggests a connection between ATF4 and the mitochondria in basal 
conditions.  Cardiolipin has been associated with maintaining mitochondrial 
structure through a role in mitochondrial fusion/fission events and its association 
with members of the electron transport chain [118].  The reduction in cardiolipin 
synthetase mRNA and protein in ATF4-deleted livers (Figure 3-8, A and B) would 
suggest a more glycolytic means of energy production due to the role of 
cardiolipin in electron transport.  The glycolytic pathway is preferred during 
periods of stress as ATF4 drives expression of CTH resulting in the sulfhydration 
of metabolic proteins, like pyruvate kinase 2, which results in increased activity 
promoting glycolysis [123].  The inhibition of CTH, however, prevents this 
increase in activity, and the loss of ATF4 reduces CTH expression and 
sulfhydration levels, and would be suggested to prevent the increase in pyruvate 
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kinase 2 activity typically seen during stress.  These metabolic alterations could 
also explain why ATF4-/- MEF cells have a reduced growth rate [6].  Cells that are 
depleted for ATF4 show basal oxidative stress, along with sub-optimal oxidative 
phosphorylation due to the reduced cardiolipin levels, while being unable to 
optimally increase their glycolytic activity during periods of stress. 
The role of ATF4 in metabolism, along with its differing functions in 
development among tissues suggest that a wide range of transcription factors 
can directly or indirectly interact with ATF4 to elicit its downstream effects on the 
target gene.  This wide range of ATF4 effects, even in light of a reduced yet more 
specialized role within the UPR, suggest there is much more to learn about 
ATF4. 
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